title: [Greenlight-XPS laser vaporization, the new standard of treatment in men with myasthenia gravis and benign prostatic obstruction]?
abstract: Patients with Benign Prostatic Obstruction (BPO) and Myasthenia Gravis (MG) treated with Transurethral Resection of the prostate (TURP) show a high incidence of urinary incontinence due to unnoticed damage to muscle fibres of the external sphincter. Photoselective laser vaporization could be an alternative treatment based on the hypothesis that using Laser as energy source in the treatment of BPH prevents sphincter damage because the energy is not transmitted outside the fiber tip.
  
  
  METHODS
  We report the case of a man diagnosed of MG and symptomatic BPO treated satisfactorily with photoselective laser vaporization (GreenLight-XPS).
  
  
  RESULTS
  Patient did not experienced postoperative secondary incontinence.
  
  
  CONCLUSIONS
  Laser photoselective vaporization (GreenLight-XPS) could be the standard treatment for men with MG and BPO, whose prostate volume is less than 60 cc who are candidates for surgical treatment. Despite the extremely low incidence of these cases, further investigations are needed to confirm this affirmation.
authors.affiliation: Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España.
authors.forename: Adrián
authors.initials: A
authors.lastname: Husillos-Alonso
authors.affiliation: Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España.
authors.forename: Carlos
authors.initials: C
authors.lastname: Simón-Rodríguez
authors.affiliation: Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Bolufer-Moragues
authors.affiliation: Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España.
authors.forename: Leticia
authors.initials: L
authors.lastname: López-Martín
authors.affiliation: Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España.
authors.forename: Manuel
authors.initials: M
authors.lastname: Carbonero-García
authors.affiliation: Servicio de Urología. Hospital Universitario Infanta Elena (HUIE). Universidad Francisco de Vitoria (UFV) / Hospital Universitario Fundación Jiménez Díaz (FJD). Universidad Autónoma de Madrid (UAM). Madrid. España.
authors.forename: Carmen
authors.initials: C
authors.lastname: González-Enguita
mesh_terms: D000368:Aged; D006801:Humans; D053685:Laser Therapy; D008297:Male; D009157:Myasthenia Gravis / Q000150:complications*; D011470:Prostatic Hyperplasia / Q000150:complications* / Q000601:surgery*; D014524:Urethral Obstruction / Q000209:etiology* / Q000601:surgery*; D014549:Urinary Incontinence